| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 310.51B | 334.61B | 302.68B | 261.60B | 272.17B | 253.57B |
| Gross Profit | 39.17B | 41.35B | 38.82B | 33.39B | 31.03B | 28.02B |
| EBITDA | 12.00B | 13.87B | 14.39B | 11.57B | 11.17B | 8.95B |
| Net Income | 5.99B | 6.84B | 6.74B | 5.94B | 5.78B | 4.63B |
Balance Sheet | ||||||
| Total Assets | 190.36B | 214.13B | 183.63B | 162.02B | 147.99B | 132.09B |
| Cash, Cash Equivalents and Short-Term Investments | 7.53B | 11.05B | 7.51B | 8.45B | 7.05B | 6.54B |
| Total Debt | 85.25B | 92.10B | 79.92B | 74.62B | 68.97B | 58.12B |
| Total Liabilities | 120.31B | 135.26B | 115.27B | 103.16B | 101.02B | 89.91B |
| Stockholders Equity | 68.30B | 77.34B | 66.52B | 58.98B | 47.54B | 42.70B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -3.98B | -314.00M | -7.06B | -8.54B | -5.99B |
| Operating Cash Flow | 0.00 | -745.00M | 5.84B | -1.72B | -6.24B | -1.13B |
| Investing Cash Flow | 0.00 | -5.22B | -9.00B | -5.71B | -2.34B | -5.22B |
| Financing Cash Flow | 0.00 | 9.08B | 2.15B | 8.52B | 9.01B | 5.74B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥1.14T | 15.47 | 13.07% | 1.82% | 5.72% | 13.87% | |
72 Outperform | ¥32.94B | 12.35 | ― | 1.96% | 0.57% | 7.20% | |
65 Neutral | ¥402.14B | 14.57 | 10.18% | 2.56% | 5.09% | 10.53% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
60 Neutral | ¥458.06B | 16.71 | 9.86% | 2.58% | 2.00% | 12.21% | |
58 Neutral | ¥52.87B | 7.69 | 10.55% | 2.68% | 10.55% | 1.50% | |
56 Neutral | ¥564.71B | 14.42 | 6.04% | 2.04% | 6.34% | 38.64% |